Emre E. Turer
Impact in
- Immunology top 1%
- Immune Response and Inflammation
- interferon and immune responses
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Cancer Research top 2%
- NF-κB Signaling Pathways
Papers in
-
- CRISPR and Genetic Engineering 2
- Signaling Pathways in Disease 1
- Metabolism, Diabetes, and Cancer 1
-
- Immune Response and Inflammation 8
- interferon and immune responses 4
- Immune cells in cancer 2
- Co-authors
- Averil Ma (7 shared papers)Osamu Hitotsumatsu (3 shared papers)Barbara A. Malynn (6 shared papers)Rommel Advincula (6 shared papers)Rizwan Ahmad (2 shared papers)Sophia Chai (2 shared papers)David L. Boone (1 shared paper)Marcia Chien (1 shared paper)
- Journals
- Disease Models & Mechanisms (3 papers)Immunity (3 papers)Proceedings of the National Academy of Sciences (3 papers)Nature Immunology (2 papers)Nature Communications (2 papers)
- Partner nations
- United StatesPortugalSweden
In The Last Decade
Emre E. Turer
19 papers receiving 2.2k citations
Emre E. Turer's Hit Papers
Peers
Comparison fields: 5 of 87
- Immunology 1.6k
- Cancer Research 995
- Molecular Biology 997
- Immunology and Allergy 57
- Oncology 248
Countries citing papers authored by Emre E. Turer
This map shows the geographic impact of Emre E. Turer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emre E. Turer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emre E. Turer more than expected).
Fields of papers citing papers by Emre E. Turer
This network shows the impact of papers produced by Emre E. Turer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emre E. Turer. The network helps show where Emre E. Turer may publish in the future.
Co-authors
The 25 scholars most cited alongside Emre E. Turer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses Hit paper breakdown → | 2004 | 889 |
| 2 | 2008 | 280 | |
| 3 | 2008 | 224 | |
| 4 | 2011 | 212 | |
| 5 | 2010 | 201 | |
| 6 | 2008 | 135 | |
| 7 | 2013 | 117 | |
| 8 | 2021 | 59 | |
| 9 | 2017 | 56 | |
| 10 | 2016 | 33 | |
| 11 | 2019 | 17 | |
| 12 | 2018 | 15 | |
| 13 | 2018 | 9 | |
| 14 | 2023 | 8 | |
| 15 | 2024 | 5 | |
| 16 | 2018 | 5 | |
| 17 | 2019 | 3 | |
| 18 | 2021 | 3 | |
| 19 | 2023 | 2 |
About Emre E. Turer
Emre E. Turer is a scholar working on Molecular Biology, Immunology, Cancer Research, Surgery and Nutrition and Dietetics, having authored 19 papers that have together received 2.3k indexed citations. Recurring topics across this work include Immune Response and Inflammation (8 papers), NF-κB Signaling Pathways (8 papers), interferon and immune responses (4 papers), Pancreatic function and diabetes (2 papers), CRISPR and Genetic Engineering (2 papers), Immune cells in cancer (2 papers), Signaling Pathways in Disease (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). The work is most often cited by research in Immunology (1.6k citations), Cancer Research (995 citations), Molecular Biology (997 citations), Immunology and Allergy (57 citations) and Oncology (248 citations). Emre E. Turer has collaborated with scholars based in United States, Portugal and Sweden. Frequent co-authors include Averil Ma, Osamu Hitotsumatsu, Barbara A. Malynn, Rommel Advincula, Rizwan Ahmad, Sophia Chai, David L. Boone, Marcia Chien, Cecile M. Pickart and Matthew T. Wheeler. Their work appears in journals such as Disease Models & Mechanisms, Immunity, Proceedings of the National Academy of Sciences, Nature Immunology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.